• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Biotech

Digital molecular structure
Biotech

NIH earmarks $87M for new organoid center

The center’s goal will be to develop standardized organoid models that can be used for preclinical testing of potential new drugs.
Darren Incorvaia Sep 25, 2025 11:55am
cancel

Lilly withdraws phase 2 obesity trial before starting enrollment

Sep 25, 2025 8:07am
Getting to Yes How Deal-Making Fuels Biotech Growth
Sponsored

Getting to Yes: How Deal-Making Fuels Biotech Growth

Sep 17, 2025 3:20pm
 Large layoffs of employees Wooden figures of people going to the exit

Heidelberg to ax 75% of staff after milestone becomes millstone

Sep 25, 2025 7:20am
Carl Sailer on AI market trends and strategic planning in biotech
Sponsored

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
research deal two people shaking hands in lab

Merck opts in on Evaxian's preclinical vaccine candidate

Sep 25, 2025 7:00am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings